Back to company

CHRETO ApS: Financial statements 2014

CVR: 33382170

CHRETO ApS (CVR 33382170) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,711 and a net result of DKK 4,711 compared with DKK 13,142 the year before. That is a decrease of 63.9% compared with the year before. Equity amounted to DKK 167,143. The solvency ratio was 9.9%.

Gross Profit
4,711 kr.
Profit/Loss
4,711 kr.
Equity
167,143 kr.
Total Assets
1,686,269 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-5 t.5 t.167 t.-
2013-13 t.13 t.162 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CHRETO ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

Torben Vedel Stahl Jørgensen joins the board of CHRETO ApSSep 13, 2014

As of September 13, 2014, Torben Vedel Stahl Jørgensen has joined the board of directors of CHRETO ApS.

Geert W Nygaard joins the board of CHRETO ApSSep 13, 2014

As of September 13, 2014, Geert W Nygaard has joined the board of directors of CHRETO ApS.

Geert W Nygaard leaves the board of CHRETO ApSSep 13, 2014

As of September 13, 2014, Geert W Nygaard has left the board of directors of CHRETO ApS.

About CHRETO ApS

CHRETO ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kyhse-Andersen. The company's owners include NOVOZYMES A/S, SKEIKAMPEN INVEST ApS and JAN KYHSE-ANDERSEN HOLDING ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK -2,662,874 and a net result of DKK -3,119,901 compared with DKK -2,336,562 the year before. Equity amounted to DKK 49,010,862.